Combined Vancomycin and Piperacillin-Tazobactam Treatment Is Not Associated with Acute Kidney Injury (AK) When Assessed Using Plasma Cystatin C
Todd A. Miano(University of Pennsylvania), M.G.S. Shashaty(University of Pennsylvania), Sean Hennessy(Translational Therapeutics (United States)), Ariel R. Weisman(University of Pennsylvania), R.S. Agyekum(Translational Therapeutics (United States)), Brian J. Anderson(University of Pennsylvania), Tiffanie K. Jones(University of Pennsylvania), Christopher D. Ittner(University of Pennsylvania), H.M. Giannini(Lung Institute), Christopher V. Cosgriff(University of Pennsylvania), John P. Reilly(University of Pennsylvania), N.J. Meyer(Pulmonary and Allergy Associates), Oluwatosin Oniyide(University of Pennsylvania), T. Dunn(Hospital of the University of Pennsylvania)
Cited by 0
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Are Nonfinancial Measures Leading Indicators of Financial Performance? An Analysis of Customer Satisfaction
|Journal of Accounting Research|1998|1.6k
Assessing empirical research in managerial accounting: a value-based management perspective
|Journal of Accounting and Economics|2001|1.2k
Performance implications of strategic performance measurement in financial services firms
|Accounting Organizations and Society|2003|1k
Subjectivity and the Weighting of Performance Measures: Evidence from a Balanced Scorecard
|The Accounting Review|2003|885